InflaRx NV
NASDAQ:IFRX

Watchlist Manager
InflaRx NV Logo
InflaRx NV
NASDAQ:IFRX
Watchlist
Price: 2.03 USD 18.71% Market Closed
Market Cap: 119.5m USD
Have any thoughts about
InflaRx NV?
Write Note

InflaRx NV
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

InflaRx NV
Cost of Revenue Peer Comparison

Comparables:
BNTX
MOR
IMTX
BIO
FYB

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
InflaRx NV
NASDAQ:IFRX
Cost of Revenue
-€1.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
BioNTech SE
NASDAQ:BNTX
Cost of Revenue
-€599.8m
CAGR 3-Years
-117%
CAGR 5-Years
-112%
CAGR 10-Years
N/A
MorphoSys AG
XETRA:MOR
Cost of Revenue
-€32.8m
CAGR 3-Years
-44%
CAGR 5-Years
-37%
CAGR 10-Years
N/A
Immatics NV
NASDAQ:IMTX
Cost of Revenue
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotest AG
XETRA:BIO
Cost of Revenue
-€431.9m
CAGR 3-Years
-4%
CAGR 5-Years
-10%
CAGR 10-Years
-3%
Formycon AG
XETRA:FYB
Cost of Revenue
-€54.8m
CAGR 3-Years
-27%
CAGR 5-Years
-18%
CAGR 10-Years
N/A

See Also

What is InflaRx NV's Cost of Revenue?
Cost of Revenue
-1.1m EUR

Based on the financial report for Jun 30, 2024, InflaRx NV's Cost of Revenue amounts to -1.1m EUR.

Back to Top